Pulse Biosciences Revenue 2016-2025 | PLSE
Pulse Biosciences revenue from 2016 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Pulse Biosciences Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | |
| 2023 | |
| 2022 | $1 |
| 2021 | $1 |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
|
Pulse Biosciences Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $0 |
| 2025-06-30 | |
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | $0 |
| 2022-09-30 | |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $1 |
| 2021-09-30 | $1 |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.987B | $0.000B |
| Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $231.230B | 27.48 |
| Intuitive Surgical (ISRG) | United States | $205.316B | 80.33 |
| IDEXX Laboratories (IDXX) | United States | $57.873B | 57.47 |
| Edwards Lifesciences (EW) | United States | $48.171B | 32.30 |
| IQVIA Holdings (IQV) | United States | $41.018B | 22.87 |
| Alcon (ALC) | Switzerland | $39.884B | 26.95 |
| Mettler-Toledo (MTD) | United States | $30.479B | 35.66 |
| DexCom (DXCM) | United States | $27.683B | 38.16 |
| STERIS (STE) | Ireland | $25.594B | 26.42 |
| Waters (WAT) | United States | $23.443B | 31.00 |
| Coloplast (CLPBY) | Denmark | $20.255B | 34.57 |
| Hologic (HOLX) | United States | $16.687B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.899B | 0.00 |
| Penumbra (PEN) | United States | $12.511B | 88.01 |
| Globus Medical (GMED) | United States | $12.276B | 25.76 |
| Masimo (MASI) | United States | $7.103B | 22.76 |
| Sysmex ADR (SSMXY) | Japan | $6.421B | 20.40 |
| Glaukos (GKOS) | United States | $6.370B | 0.00 |
| Teleflex (TFX) | United States | $4.798B | 7.65 |
| TransMedics (TMDX) | United States | $4.602B | 54.52 |
| Veracyte (VCYT) | United States | $3.435B | 39.14 |
| LivaNova (LIVN) | United Kingdom | $3.406B | 18.40 |
| Integer Holdings (ITGR) | United States | $2.928B | 13.74 |
| Alphatec Holdings (ATEC) | United States | $2.613B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.407B | 22.52 |
| Artivion (AORT) | United States | $2.032B | 93.24 |
| UFP Technologies (UFPT) | United States | $1.997B | 26.36 |
| Nihon Kohden (NHNKY) | Japan | $1.986B | 17.34 |
| PROCEPT BioRobotics (PRCT) | United States | $1.751B | 0.00 |
| AxoGen (AXGN) | United States | $1.455B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.448B | 0.00 |
| IRadimed (IRMD) | United States | $1.245B | 59.33 |
| Integra LifeSciences Holdings (IART) | United States | $1.024B | 5.55 |
| OPKO Health (OPK) | United States | $1.021B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.777B | 0.00 |
| SiBone (SIBN) | United States | $0.775B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.667B | 38.79 |
| Pacific Biosciences Of California (PACB) | United States | $0.607B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.604B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.601B | 0.00 |
| NeuroPace (NPCE) | United States | $0.563B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.556B | 11.08 |
| OrthoPediatrics (KIDS) | United States | $0.504B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.464B | 12.80 |
| ClearPoint Neuro (CLPT) | United States | $0.445B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.420B | 0.00 |
| RxSight (RXST) | United States | $0.415B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.392B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.363B | 60.53 |
| Semler Scientific (SMLR) | United States | $0.344B | 2.57 |
| Spectral Diagnostics (EDTXF) | Canada | $0.299B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.196B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.187B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.150B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.143B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| Solana (HSDT) | United States | $0.133B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Accuray (ARAY) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.084B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.065B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.021B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.46 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |